Harte-Hanks hires Hartman from Horn

Share this article:
Glen Hartman has joined Harte-Hanks as SVP, digital marketing. He will be leading various marketing strategies on behalf of the firm's healthcare clients, which include Shire, AstraZeneca, Genentech and Teva.

“Over the past few years Harte-Hanks has done over 280 interactive projects ranging from consulting and strategic planning all the way to tactical things built around Web site development and relationship programs,” Hartman says. “One of my main goals is really just to build upon that. Helping our clients optimize customer interactions through different channels is probably the most exciting aspect of that and is at the forefront of my strategy moving forward.”

Previously, Hartman was managing director at Horn group, where he helped launch its digital marketing practice.

Harte-Hanks has also promoted Jeanette Kocsis from director of online marketing to the position of VP, digital marketing. She will be responsible for client guidance and day-to-day management of the digital and integrated marketing teams.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Channel

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...